BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades [...]

SOUTH SAN FRANCISCO, Calif. --  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a drug discovery agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”) to discover and develop novel antibodies for the treatment of autoimmune diseases. [...]

PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) will move the headquarters functions of PHCHD and its wholly-owned subsidiary PHC Corporation to a new location in Tokyo: the Dai-ichi Life Hibiya First building near Hibiya Park. The relocation was approved at the 10th Annual General Meeting of [...]

The World’s First Automated Extraction and Recovery Process for Microplastics Analysis Shimadzu Corporation announces the release of the MAP-100 automatic microplastics pretreatment unit. This product is the first in the world to automate the process of extracting and collecting microplastics in oceans, rivers, lakes, and other water in the environment. Before instrumental microplastic analysis, it [...]

Cambridge, UK: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr. Tomasz Kostrzewski as Chief Scientific Officer. Previously Vice President of Science and Technology, Dr. Kostrzewski’s promotion creates a new position in CN Bio’s leadership team, marking another key milestone in the [...]

The hospital is using the SOPHiA DDM™ Platform to advance the research of Homologous Recombination Repair Mutated Cancers BOSTON and ROLLE -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that CHU Bordeaux, a full-service hospital servicing the population of Bordeaux and the surrounding area, has completed implementation of [...]

Agreements Will Help Drive Greater Accuracy of Epigenetic Information for the Early Detection of Cancer BOULDER,CO – Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact Sciences Corporation, a leading provider of cancer screening and diagnostic tests, to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine [...]

Strategic distribution agreement with Research Instruments expands access to BioSkryb’s best-in-class single-cell multiomics portfolio throughout Southeast Asia DURHAM, N.C. –  BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced a partnership with Research Instruments Pte Ltd, a premier distributor for genomic [...]

ANN ARBOR, Mich. -- Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their 'Human T Cell Activation & Expansion Kit' with Buoyancy Activated Cell Sorting (BACS) microbubbles. The first of its kind kit is designed to isolate, activate, and expand T cells from a sample in one [...]

SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial Officer, effective August 28, 2023. As CFO, Kullback will be responsible for the Company's financial planning and analysis, accounting, internal audit, tax, and treasury functions. “Bill’s deep industry knowledge, [...]